ProPhase Labs
OTC: PRPHUniondale, US · Delaware corporation · 46 employees on LinkedIn
Find your way into ProPhase Labs
35 people in our graph share verified history with the ProPhase Labs team — schools, employers, funds. One of them is your warm intro.
Roger Krakoffunlockedknows Ted Karkus · together at Tufts University (overlapped)
×7knows the team · via Columbia Business School
×4knows the team · via Tufts University
ProPhase Labs appears to operate multiple subsidiary companies including Nebula Genomics, ProPhase Biopharma, and TK Supplements, but detailed information about the company's primary business, products, and market focus is not available on this investor relations presentations page.
Founders & leadership
KL
Kevin LeeCo-founder of Nebula Genomics
GC
George ChurchCo-founder of Nebula Genomics
TK
Ted KarkusinCEO and ChairmanHe previously led ID Biomedical (sold to GlaxoSmithKline for $1.4 billion) and served as CEO of ProPhase Labs' predecessor, overseeing the Cold-EEZE product line before its sale to Mylan.
RV
Robert V. Cuddihy, Jr.Executive
Board
CA
CAROLINA ABENANTEBoard director
WH
WARREN HIRSCHBoard director
LG
LOUIS GECKELBoard director
LG
Louis GleckelBoard director
JM
James McCubbinBoard director
MB
Mark BurnettBoard director
JB
Jason BarrBoard director
ML
Mark LeventhalBoard director
Reported raises · per SEC filings
Form D private placements$5.5M disclosed across 3 rounds · 2015–2025
▶$3MraisedAug 2025 · 2 investors · BiotechnologyRule 506(b)
▶$3MraisedAug 2025 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- LOUIS GECKELDirector
- WARREN HIRSCHDirector
- CAROLINA ABENANTEDirector
- TED KARKUSExecutive Officer, Director
- Offering amount
- $6M
- Amount sold
- $3M
- Minimum investment
- $500K
- First sale
- Jul 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1MraisedJul 2025 · 2 investors · BiotechnologyRule 506(b)
▶$1MraisedJul 2025 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- CAROLINA ABENANTEDirector
- WARREN HIRSCHDirector
- LOUIS GECKELDirector
- TED KARKUSExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $1M
- Minimum investment
- $500K
- First sale
- Jun 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.5MraisedDec 2015 · 2 investors · PharmaceuticalsRule 506(b)
▶$1.5MraisedDec 2015 · 2 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Louis GleckelDirector
- Robert V. Cuddihy, Jr.Executive Officer
- James McCubbinDirector
- Mark BurnettDirector
- Jason BarrDirector
- Mark LeventhalDirector
- Ted KarkusExecutive Officer, Director
- Offering amount
- $3M
- Amount sold
- $1.5M
- First sale
- Dec 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlap
Labcorp37 shared keywordsLabCorp provides diagnostic testing services and clinical trial recruitment solutions that connect patient insights to drug development for healthcare providers.
IQVIA32 shared keywordsIQVIA is a healthcare data and technology company that supports life sciences organizations in research, clinical development, and commercialization of medicines and medical solutions.
Robinhood24 shared keywordsRobinhood is a financial trading platform that enables users to manage portfolios across stocks, ETFs, cryptocurrencies, options, futures, and prediction markets. The platform serves retail investors with low barriers to entry, offering portfolio management services and market insights.
Companies competing with ProPhase Labs for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
ProPhase Labs leads stock surge with 506% gain ... | Pluangpluang.com · Aug 2026Frequently asked questions
- What does ProPhase Labs do?
- ProPhase Labs appears to operate multiple subsidiary companies including Nebula Genomics, ProPhase Biopharma, and TK Supplements, but detailed information about the company's primary business, products, and market focus is not available on this investor relations presentations page.
- Who founded ProPhase Labs?
- ProPhase Labs was founded by Kevin Lee, George Church.
- How much funding has ProPhase Labs raised?
- ProPhase Labs has disclosed $5.5M raised across 3 rounds.
- Where is ProPhase Labs headquartered?
- ProPhase Labs is headquartered in Uniondale, US.